Neutral immersion bath on Myalgia in patients with post COVID-19

“Evaluating the efficiency of neutral immersion bath on Myalgia in patients with post COVID-19 infection- A Randomised control trial ?

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/047993

Enrollment

Registered

2022-12-12

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M791- Myalgia

Interventions

Intervention1: NEUTRAL IMMERSION BATH: 30 minutes of neutral immersion bath daily for 10 days. Control Intervention1: patients who are with or without Medications followed up for 10 days: Compared to

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects who are willing to participate in the study. 2. Post COVID-19 subjects with RTP-CR negative after COVID-19 infection.

Exclusion criteria

Exclusion criteria: 1. Subjects with active COVID-19 or RTP-CR positive patients. 2. Subjects with COVID-19 and other comorbidities. 3. Post COVID-19 subjects who are under statins.

Design outcomes

Primary

Measure	Time frame
Universal Pain Assessment Tool (UPAT) Timepoint: After 10 days- 0-10 scale of Universal Pain Assessment Tool (UPAT) reading should be towards 0.	—

Secondary

Measure	Time frame
Brief Pain Inventory (BPI):Timepoint: After 10 days- 0-10 scale of Brief Pain Inventory (BPI) reading should be towards 0. ;Creatine kinase (CK) testTimepoint: After 10 days- less than 320 IU/L for men less than 200 IU/L for women than pre intervention study	—

Countries

India

Contacts

Public ContactDr Prajna

Alvas College of Naturopathy and Yogic Sciences

dr.lakshmeesh@gmail.com7674872784

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026